Cargando…

Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping

Acute lymphoblastic leukemia (ALL) is a malignancy that can be subdivided into distinct entities based on clinical, immunophenotypic and genomic features, including mutations, structural variants (SVs), and copy number alterations (CNA). Chromosome banding analysis (CBA) and Fluorescent In‐Situ Hybr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rack, Katrina, De Bie, Jolien, Ameye, Geneviève, Gielen, Olga, Demeyer, Sofie, Cools, Jan, De Keersmaecker, Kim, Vermeesch, Joris R., Maertens, Johan, Segers, Heidi, Michaux, Lucienne, Dewaele, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314940/ https://www.ncbi.nlm.nih.gov/pubmed/35119131 http://dx.doi.org/10.1002/ajh.26487

Ejemplares similares

Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing
por: Meyers, Sarah, et al.
Publicado: (2022)

BCR-ABL1 positive B-ALL can undergo T-cell lineage shift to become CD19 negative T-ALL
por: De Bie, Jolien, et al.
Publicado: (2018)

Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia
por: De Bie, Jolien, et al.
Publicado: (2018)

Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia
por: Verbeke, Delphine, et al.
Publicado: (2019)

Noninvasive prenatal testing detected acute myeloid leukemia in paucisymptomatic pregnant patient
por: Rengifo, Laura Yissel, et al.
Publicado: (2020)

PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia
por: Govaerts, Inge, et al.
Publicado: (2021)

Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia
por: Vandersmissen, Charlien, et al.
Publicado: (2023)

TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia
por: Thielemans, Naomi, et al.
Publicado: (2022)

Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified
por: Debackere, Koen, et al.
Publicado: (2021)

Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia
por: Vanden Bempt, Marlies, et al.
Publicado: (2018)

Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia
por: Van Thillo, Quentin, et al.
Publicado: (2021)

Computational fluid dynamics model to predict the dynamical behavior of the cerebrospinal fluid through implementation of physiological boundary conditions
por: Vandenbulcke, Sarah, et al.
Publicado: (2022)

CRISPR screening in hematology research: from bulk to single-cell level
por: Meyers, Sarah, et al.
Publicado: (2023)

EML1–ABL1 Is Activated by Coiled-Coil-Mediated Oligomerization and Induces T-Cell Acute Lymphoblastic Leukemia or Myeloproliferative Disease in a Mouse Bone Marrow Transplant Model
por: Vanden Bempt, Marlies, et al.
Publicado: (2018)

The CCR4-NOT complex is a tumor suppressor in Drosophila melanogaster eye cancer models
por: Vicente, Carmen, et al.
Publicado: (2018)

Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma
por: Silva, Ana, et al.
Publicado: (2021)

Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system
por: Bornschein, S, et al.
Publicado: (2018)

Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies
por: Lenaerts, Liesbeth, et al.
Publicado: (2021)

Mechanisms underlying transcription factor deregulation in acute lymphoblastic leukemia
por: Cools, Jan
Publicado: (2018)

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia
por: Degryse, Sandrine, et al.
Publicado: (2015)

Case Report: Spontaneous Remission of an Infraorbital Follicular B-Cell Lymphoma: Case Report and Review of the Literature
por: Peeters, Maxime, et al.
Publicado: (2021)

JAK3 mutations and HOXA9 expression are important cooperating events in T-cell acute lymphoblastic leukemia
por: de Bock, Charles E., et al.
Publicado: (2018)

Comprehensive Analysis of Transcriptome Variation Uncovers Known and Novel Driver Events in T-Cell Acute Lymphoblastic Leukemia
por: Kalender Atak, Zeynep, et al.
Publicado: (2013)

Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells
por: Kampen, Kim R., et al.
Publicado: (2019)

Development of a portable on-site applicable metagenomic data generation workflow for enhanced pathogen and antimicrobial resistance surveillance
por: Bloemen, Bram, et al.
Publicado: (2023)

RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response
por: Hofman, Isabel JF, et al.
Publicado: (2016)

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
por: Degryse, S, et al.
Publicado: (2018)

Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
por: Degryse, S., et al.
Publicado: (2018)

A microfluidics-enabled automated workflow of sample preparation for MS-based immunopeptidomics
por: Li, Xiaokang, et al.
Publicado: (2023)

Transcription factor NKX2–1 drives serine and glycine synthesis addiction in cancer
por: Heylen, Elien, et al.
Publicado: (2023)

Shifting national surveillance of Shigella infections toward geno‐serotyping by the development of a tailored Luminex assay and NGS workflow
por: Ventola, Eleonora, et al.
Publicado: (2019)

Development of an NGS-Based Workflow for Improved Monitoring of Circulating Plasmids in Support of Risk Assessment of Antimicrobial Resistance Gene Dissemination
por: Berbers, Bas, et al.
Publicado: (2020)

Chromosomal phenotypes and submicroscopic abnormalities
por: Devriendt, Koen, et al.
Publicado: (2004)

The 22q11.2 Low Copy Repeats
por: Vervoort, Lisanne, et al.
Publicado: (2022)

A systematic review on literature-based discovery workflow
por: Thilakaratne, Menasha, et al.
Publicado: (2019)

Age- and Intravenous Methotrexate-Associated Leukoencephalopathy and Its Neurological Impact in Pediatric Patients with Lymphoblastic Leukemia
por: Rijmenams, Ilona, et al.
Publicado: (2021)

Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients
por: Thomson, Ashlee J., et al.
Publicado: (2023)

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma
por: Vanden Bempt, Marlies, et al.
Publicado: (2022)

Designing an Herbarium Digitisation Workflow with Built-In Image Quality Management
por: Nieva de la Hidalga, Abraham, et al.
Publicado: (2020)

Refinement of 1p36 Alterations Not Involving PRDM16 in Myeloid and Lymphoid Malignancies
por: Duhoux, Francois P., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_17gkcfjc9cjgqkms162ouh5rug